August 21, 2023

Market forces affecting the ambulatory surgery industry

Ambulatory is the term the industry is “stuck with” because that is the name the founders came up with in 1970, says David Shapiro, MD, CASC, CPHRM, LHR, an anesthesiologist with extensive experience in ambulatory surgery management and a member of the Accreditation Association for Ambulatory Health Care (AAAHC) board. “I’m not really sure this is a good term for us anymore because it applies not only to ambulatory surgery centers (ASCs) but to the entire outpatient arena including hospital outpatient departments (HOPDs) and physicians’ offices and clinics,” he says.

Regardless of the actual definition of ambulatory, however, outpatient care is on the ascent throughout the country, and the highest projected 10-year growth is in ASCs. Dr Shapiro spoke on “The state of the ambulatory surgery industry” at the 2023 AORN Global Surgical Conference & Expo.

 

Certificate of need

David Shapiro, MD, CASC, CPHRM, LHR

Certain state laws require a certificate of need (CON) to operate an ASC. CON applications are typically reviewed by the state department of health and awarded only when capacity is needed within a market. State CON programs were implemented with the intention of controlling escalating healthcare costs by reducing excess capacity.

“Just a couple of years ago, about 27 states required a CON,” says Dr Shapiro. “That has really driven the industry.” In states requiring a CON, the number of ASCs per 100,000 persons was approximately 1.7, compared to 1.9 for states that did not require it.

In the beginning, the CON states had a really hard time getting ASCs up and running, and one of the things that fought against them was the hospital industry. However, the “tide has turned” now, and hospitals are some of the major owners of ASCs, he says.

 

Current state of ASC growth

For the first few years, Medicare did not recognize ASCs, but today Medicare drives a lot of what ASCs do every day, says Dr Shapiro.

The number of Medicare-licensed ASCs increased 5.3% compounded annually from approximately 3,134 in 2000 to 5,241 in 2010, he says. These included single-specialty and multi-specialty ASCs.

Several factors have contributed to the growth in the number of ASCs:

• The migration of surgical services to the outpatient setting driven by medical and technological advances. “We are doing much higher acuity procedures and patients than we used to do, and our ability to adapt has really encouraged and facilitated our growth,” says Dr Shapiro.

• Patient and physician convenience and performance on safety and quality metrics has “convinced practitioners that they can deliver a higher level of care in ASCs, which has also encouraged that growth,” he says.

• Costs are lower, compared to surgical procedures performed in the hospital setting.

ASC facility growth has slowed since 2010, with the number of ASCs increasing just 1.3% to 6,028 Medicare-certified ASCs in September 2021. Consolidation of management companies, physician employment by hospitals, and volume pressure resulting from the proliferation of high-deductible health plans have contributed to the slowed growth.

However, revenue growth is expected to outpace growth in the number of facilities, driven by the migration of cardiac, spine, and orthopedic cases from hospital-based settings.

 

ASCs by specialty/combinations

In the early days, ASCs were mostly single-specialty, but currently the rate of growth of multi-specialty ASCs is predominant, says Dr Shapiro. The average number of ORs in multi-specialty ASCs is higher because they are typically bigger—about 3.4 or 4 rooms is the average for multi-specialty and about 2.5 rooms for single-specialty.

The trend for orthopedics has really taken off, he says, adding that a lot of the ASCs he visits as an AAAHC surveyor are orthopedic or pain centers. Much of the growth in orthopedics has been driven by advances such as robotics and instruments that allow for much more minimally invasive procedures.

Another trend is specialty combination ASCs. The top two-specialty combinations are orthopedic/pain (17%), ophthalmologic/plastic (12%), and endoscopy/other (10%).

 

Who is paying for ASC services?

Medicare is paying for about 35% of ASC services, and commercial payers are paying for about 45%.

Commercial payers have entered the ASC market because they realize how great ASCs are at providing good care, says Dr Shapiro. The advantage of commercial payers that is helpful to ASCs is they are more advanced and more realistic than Medicare, he says.

The prevalence of commercial payers has allowed ASCs to grow, while Medicare tends to stifle growth. Each year Medicare changes what they will pay ASCs per procedure, what ASCs have to report for quality measures, and what ASCs are allowed to do or not do. “This makes it hard to plan, when the final payment rule isn’t released until November or December for changes that will take place on January 1,” he says.

Dr Shapiro notes that commercial payers who pay for procedures on patients who are old enough to be on Medicare help ASCs gather data and prove to Medicare that ASCs can safely do procedures on patients who are more than 65 years old.

 

Challenges

The ASC industry is facing several challenges.

Boosting case volume. The COVID-19 pandemic and other natural disasters depressed ASC volume because centers temporarily shut down or discontinued elective procedures. Dr Shapiro notes that the ASC industry is now working on redefining elective procedures for the future.

“The bottom line is that we really need to be careful about what we call elective because, as we found in the backlog of cases, patients started having larger problems that could have been taken care of when they were smaller and prevented disease progression,” he says.

Dr Shapiro adds that he has suggested to legislative committees that future wording should be more along the lines of non-emergent. In other words, he says, a case that needs to be done may not have to be done within 5 to 10 minutes, but it should not have to wait 6 months or even 1 month.

Case volume is always going to be a challenge in ASCs, he says, which is why administrators always need to be looking at what other services they might want to provide, expanding their facilities, adding partnerships, or accepting alternative payment plans.

Industry consolidation. Insurance companies are consolidating and creating narrow networks that exclude small groups and providers in some markets, and ASCs have few options if they are left out of the networks or offered low rates.

When this happens, ASC owners may consider selling to a hospital, joining a national chain, or entering direct contracting with large employers to offer value-based services. Some consolidation also has been caused by consolidation of ASC management companies, says Dr Shapiro.

Negotiating with insurers. Commercial insurers may be eager to move cases to ASCs, but that doesn’t mean their rates will be favorable. Payers are anticipating an influx of members having surgical procedures postponed by the pandemic, and they will be more aggressive in negotiations than in the past.

“In a lot of markets, they have made back-door deals with big hospital systems. If those systems don’t have a financial relationship with your ASC, you might be left on the sidelines with trying to negotiate to do certain patients and procedures on your own,” he says.

Transparency mandates. The federal government requires hospitals to post negotiated payer rates online for hundreds of common services, and similar mandates could be applied to ASCs in the future. Increased price transparency could be a boon for ASCs as the low-cost provider, but it could also depress prices in competitive markets.

“I think we have to be really careful because, rather than being known as the low-cost provider, like a Walmart, I want us to be like a Tiffany or a Nordstrom, where patients go because they know they will get high-quality care on a consistent basis,” says Dr Shapiro.

Hospital competition. The pandemic drove more high-acuity cases to ASCs, including joint replacements and spine procedures. These specialties are high-reimbursing for hospitals, and the continued migration of these procedures will trigger more competition between independent and hospital-based ASCs and encourage more hospitals to build ASCs of their own. Some experts foresee hospitals increasing lobbying efforts at the state and national level to increase regulations and barriers to entry for ASCs, he says.

Increasing costs. “You have to really watch your costs in the ASC environment because your margins are so thin,” says Dr Shapiro. Examples of increasing costs include robotics costs. Orthopedic surgeons are training on robotic technology at higher rates than in the past and want to use them in ASCs.

Even with pricing structure designed for ASCs, robotic systems are a large expense. However, ASC administrators are trying to find room for them in the budget to attract more surgeons and compete with hospitals.

There also are growth costs for ASCs that went into “stealth mode” during the pandemic instead of moving ahead with growth plans, he says. “They may have a bigger bottom line now, but value for a potential sale is lower because their valuation depends on future potential. ASCs that did move forward with investments in technology and infrastructure have a bigger debt load now but will be more valuable in the future.”

Staffing. Though the ASC industry has mostly rebounded from the pandemic in terms of case load, the effects on staffing and supply chain remain significant. That includes a shortage of workers and high costs for everything from pharmaceuticals to equipment.

Hiring staff remains challenging because many nurses left the profession during the pandemic, and ASCs that laid off staff are having trouble replacing them. In addition, some ASCs are expanding their hours to evenings and weekends, and they are finding it difficult to staff during those off times.

 

Going forward

“I am not trying to paint a really bad picture, but we do have a lot of headwinds,” says Dr Shapiro. “I don’t consider them roadblocks, but rather, stuff that’s in the way, and we can overcome them,” he says. “We have to stay positive and stay focused on the great patient care we provide.”

 

—Judith M. Mathias, MA, BS, RN, is the clinical editor of OR Manager.

 

Reference

Shapiro D. The state of the ambulatory surgery industry. AORN Global Surgical Conference & Expo. 2023.

Join our community

Learn More
Video Spotlight
Live chat by BoldChat